BioVentrix Inc-医療機器分野:企業M&A・提携分析

◆英語タイトル:BioVentrix Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8012904
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioVentrix Inc (BioVentrix) is a medical device company that develops congestive heart failure treatment solutions. The company provides revivent myocardial anchoring systems that restore the size, volume and resulting function of the left ventricle for improving cardiac function in heart failure patients. It also provides less invasive ventricular enhancement therapy that offers a novel procedure used to improve the left ventricle efficiency in CHF patients by excluding the scarred, non-functioning portion of the left ventricle. The company’s services comprise hospital consulting services that include heart failure management crisis and heart failure management solutions. BioVentrix is headquartered in San Ramon, California, the US.

BioVentrix Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioVentrix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
BioVentrix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
BioVentrix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
BioVentrix Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
BioVentrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
BioVentrix Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Bioventrix Raises USD1.3 Million in Venture Financing 10
BioVentrix Raises Additional USD4.4 Million in Venture Financing 11
BioVentrix Raises Additional USD2.2 Million in Venture Financing 12
BioVentrix Raises Additional USD7 Million in Venture Financing 13
BioVentrix Raises USD1.2 Million in Venture Financing 14
BioVentrix Raises Additional USD5.6 Million in Venture Financing 15
BioVentrix Raises Additional USD6.3 Million in Venture Financing 16
BioVentrix Raises USD2 Million in Venture Financing 17
BioVentrix Raises Additional USD11 Million in Venture Financing 18
BioVentrix Raises USD1.1 Million in Venture Financing 19
BioVentrix Raises Additional USD1 Million in Venture Financing 20
BioVentrix Raises USD1 Million in Venture Financing 21
BioVentrix Raises US$0.5 Million In Venture Financing 22
BioVentrix Inc – Key Competitors 23
BioVentrix Inc – Key Employees 24
BioVentrix Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Corporate Communications 26
Oct 04, 2016: Steven Healy appointed as Chairman of the Board of Directors of BioVentrix 26
Product News 27
02/18/2016: BioVentrix announces the 1st Revivent-TC TransCatheter Ventricular Enhancement procedure for Ischemic Cardiomyopathy treatment in the United Kingdom 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
BioVentrix Inc, Medical Equipment, Key Facts 2
BioVentrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
BioVentrix Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
BioVentrix Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 6
BioVentrix Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
BioVentrix Inc, Deals By Market, 2011 to YTD 2017 8
BioVentrix Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Bioventrix Raises USD1.3 Million in Venture Financing 10
BioVentrix Raises Additional USD4.4 Million in Venture Financing 11
BioVentrix Raises Additional USD2.2 Million in Venture Financing 12
BioVentrix Raises Additional USD7 Million in Venture Financing 13
BioVentrix Raises USD1.2 Million in Venture Financing 14
BioVentrix Raises Additional USD5.6 Million in Venture Financing 15
BioVentrix Raises Additional USD6.3 Million in Venture Financing 16
BioVentrix Raises USD2 Million in Venture Financing 17
BioVentrix Raises Additional USD11 Million in Venture Financing 18
BioVentrix Raises USD1.1 Million in Venture Financing 19
BioVentrix Raises Additional USD1 Million in Venture Financing 20
BioVentrix Raises USD1 Million in Venture Financing 21
BioVentrix Raises US$0.5 Million In Venture Financing 22
BioVentrix Inc, Key Competitors 23
BioVentrix Inc, Key Employees 24

★海外企業調査レポート[BioVentrix Inc-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Concord New Energy Group Ltd (182):電力:M&Aディール及び事業提携情報
    Summary Concord New Energy Group Limited (Concord), formerly China WindPower Group Limited, is a clean and renewable energy company that carries out the construction, operation and maintenance of, and investment in, wind and solar power electricity generating facilities in China. Concord’s core busi …
  • Excelsior Gold Limited (EXG):企業の財務・戦略的SWOT分析
    Excelsior Gold Limited (EXG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Huishang Bank Corp Ltd:企業の戦略・SWOT・財務分析
    Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Huishang Bank Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Oval Medical Technologies Ltd-医療機器分野:企業M&A・提携分析
    Summary Oval Medical Technologies Ltd (Oval Medical), a subsidiary of SMC Ltd is a medical device company that develops revolutionary autoinjectors. The company designs and develops drug delivery devices and drug delivery solutions. Its technologies are used to deliver viscous formulations and sensi …
  • Nagasaki University:製薬・医療:M&Aディール及び事業提携情報
    Summary Nagasaki University is an educational service provider that operates graduate schools, undergraduate schools, and research institutes. The university offers under graduate level education in the fields of economics, dentistry, pharmaceutical sciences, medicine, environmental studies, enginee …
  • Eletrosul Centrais Eletricas SA:電力:M&Aディール及び事業提携情報
    Summary Eletrosul Centrais Eletricas SA (Eletrosul) is a power generation company. The company’s business activities include generation, transmission, commercialization of energy and telecommunication services. It also invests in research and development of alternative energy sources. Eletrosul’s ge …
  • Transdev Group SA:企業の戦略的SWOT分析
    Transdev Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Petrogas E&P LLC:石油・ガス:M&Aディール及び事業提携情報
    Summary Petrogas E&P LLC (Petrogas), a subsidiary of MB Holding Company LLC, is an oil and gas company that offers crude oil exploration and development services. The company explores and produces crude oil, natural gas, and other petroleum products. It holds interest in oil producing areas in onsho …
  • Northwest Biotherapeutics Inc (NWBO)-医療機器分野:企業M&A・提携分析
    Summary Northwest Biotherapeutics Inc (NW Bio) is a development stage biotechnology company. It discovers and develops immunotherapy products to treat cancer in an effective way without toxicities associated with the normal chemotherapy drugs. The company by utilizing its proprietary technology plat …
  • American Vanguard Corp (AVD):企業の財務・戦略的SWOT分析
    American Vanguard Corp (AVD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Sunstar Holding AG:企業の戦略・SWOT・財務情報
    Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report Summary Sunstar Holding AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • NIIT Ltd (NIITLTD):企業の財務・戦略的SWOT分析
    NIIT Ltd (NIITLTD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務分析
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Collegium Pharmaceutical Inc (COLL):製薬・医療:M&Aディール及び事業提携情報
    Summary Collegium Pharmaceutical Inc (Collegium) is a specialty pharmaceutical company that focuses on the development and commercialization of innovative products for treating patients suffering from pain. The company develops products based on its DETERx platform technology. DETERx offers extended …
  • Saskatchewan Telecommunications Holding Corporation:企業の戦略的SWOT分析
    Saskatchewan Telecommunications Holding Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key compe …
  • GOJO Industries Inc:企業の戦略・SWOT・財務情報
    GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report Summary GOJO Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Galectin Therapeutics Inc (GALT):企業の財務・戦略的SWOT分析
    Summary Galectin Therapeutics Inc (Galectin Therapeutics), formerly Pro-Pharmaceuticals Inc is a biotechnology company that discovers, develops and commercializes therapies for fibrotic disease and cancer. The company provides products such as GR-MD-02, GM-CT-01, and others. Its GR-MD-02 is a drug c …
  • Forendo Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Forendo Pharma Ltd (Forendo Pharma) is a drug development company that concentrates on tissue specific regulation of sex hormone effects. The company’s product pipeline include fispemifene, which is in clinical phase II development and intended for the treatment of lower urinary tract sympto …
  • W&T Offshore Inc (WTI):企業の財務・戦略的SWOT分析
    W&T Offshore Inc (WTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • The Hain Celestial Group Inc (HAIN):企業の財務・戦略的SWOT分析
    The Hain Celestial Group Inc (HAIN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆